Singapore, July 30 -- DKSH Business Unit Healthcare, a strategic healthcare solutions partner and leading provider of Market Expansion Services for pharmaceutical, over-the-counter (OTC), consumer health and medical device companies, has further expanded its prescription drug business in South Korea through a strategic partnership with Novartis, adding the hypertension treatments Diovan(R) and Exforge(R) to its portfolio.

Under the partnership, DKSH Korea will be responsible for local sales, medical affairs, and marketing activities for the two products, further strengthening its capabilities and competitiveness in the prescription drug market.

Published by HT Digital Content Services with permission from BioSpectrum Asia....